Broncus Lists on Main Board of HKEx |
| September 24, 2021 | September 2021 Bond Updates |
|
HONG KONG, Sept. 23, 2021 /PRNewswire/ -- On September 24, Broncus (02216.HK), a pioneer in the field of interventional pulmonology in China, was successfully listed on the main board of the Hong Kong Stock Exchange. Broncus, founded in 2012, is a medical device company focused on the... |
| View more at: https://www.prnewswire.com:443/news-releases/broncus-lists-on-main-board-of-hkex-301384560.html |
| Related News |
|